Ma’mon M. Hatmal

2.5k citations

61 papers · 1.9k · 1 hit paper · h-index 22

Impact in

Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Biophysics top 5%
- Electron Spin Resonance Studies

Papers in

Infectious Diseases 11
- SARS-CoV-2 and COVID-19 Research 7
Computational Theory and Mathematics 9
- Computational Drug Discovery Methods 9

Co-authors: Walhan Alshaer (20 shared papers)Mutasem O. Taha (15 shared papers)Mohammad A. I. Al-Hatamleh (15 shared papers)Rohimah Mohamud (14 shared papers)Abdalla Awidi (5 shared papers)Amin Naser Olaimat (9 shared papers)Abdulfattah Al-Kadash (1 shared paper)Alaa A. A. Aljabali (1 shared paper)
Journals: RSC Advances (3 papers)Journal of Computer-Aided Molecular Design (3 papers)Vaccines (3 papers)European Journal of Pharmacology (2 papers)PLoS ONE (2 papers)
Partner nations: Jordan United States Malaysia

In The Last Decade

Ma’mon M. Hatmal

61 papers receiving 1.8k citations

Ma’mon M. Hatmal's Hit Papers

align trajectories log scale

siRNA: Mechanism of action, challenges, and therapeutic approaches 2021 · 340 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2021 European Journal of Pharmacology

Peers

Countries citing papers authored by Ma’mon M. Hatmal

Since Specialization

Citations

This map shows the geographic impact of Ma’mon M. Hatmal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ma’mon M. Hatmal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ma’mon M. Hatmal more than expected).

Fields of papers citing papers by Ma’mon M. Hatmal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ma’mon M. Hatmal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ma’mon M. Hatmal. The network helps show where Ma’mon M. Hatmal may publish in the future.

Co-authors

The 25 scholars most cited alongside Ma’mon M. Hatmal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ma’mon M. Hatmal Line = papers co-authored together Ma’mon M. Hatmal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	siRNA: Mechanism of action, challenges, and therapeutic approaches European Journal of Pharmacology ·Walhan Alshaer, Hadil Zureigat, Arwa Al Karaki, Abdulfattah Al-Kadash, Lobna F. Gharaibeh, Ma’mon M. Hatmal, Alaa A. A. Aljabali, Abdalla Awidi Hit paper breakdown →	2021	340
2	Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects Vaccines ·Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin Naser Olaimat, Malik Hatmal, Dina M. Alhaj-Qasem, Tamadur M Olaimat, Rohimah Mohamud	2021	161
3	Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2 Cells ·Ma’mon M. Hatmal, Walhan Alshaer, Mohammad A. I. Al-Hatamleh, Malik Hatmal, Othman Smadi, Mutasem O. Taha, Ayman J. Oweida, Jennifer C. Boer	2020	149
4	HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer British Journal of Cancer ·Gottfried E. Konecny, Luana Batista do Carmo dos Santos, Boris J. N. Winterhoff, Ma’mon M. Hatmal, Gary L. Keeney, Andrea Mariani, Milissa U. Jones, Christina Neuper	2008	115
5	Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions Molecules ·Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Kamran Sattar, Suhana Ahmad, Mohd Zulkifli Mustafa, Marcelo De Carvalho Bittencourt, Rohimah Mohamud	2020	91
6	Comprehensive literature review of monkeypox Emerging Microbes & Infections ·Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin Naser Olaimat, Suhana Ahmad, Hanan Hasan, Nurfatihah Azlyna Ahmad Suhaimi, Khaled Anwer Albakri, Anas Alzyoud	2022	68
7	Computer modeling of nitroxide spin labels on proteins Biopolymers ·Ma’mon M. Hatmal, Yiyu Li, Balachandra Gajanan Hegde, Prabhavati B. Hegde, Christine C. Jao, Ralf Langen, Ian S. Haworth	2011	57
8	Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects Biomedicines ·Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin Naser Olaimat, Walhan Alshaer, Hanan Hasan, Khaled Anwer Albakri, Enas Alkhafaji, Nada N. Issa	2022	53
9	Aptamer-functionalized pH-sensitive liposomes for a selective delivery of echinomycin into cancer cells RSC Advances ·Zainab M. Lafi, Walhan Alshaer, Ma’mon M. Hatmal, Malek A. Zihlif, Dana A. Alqudah, Hamdi Nouri Nsairat, Hanan Azzam, Talal A. Aburjai	2021	51
10	Global Structure of a Three-Way Junction in a Phi29 Packaging RNA Dimer Determined Using Site-Directed Spin Labeling Journal of the American Chemical Society ·Xiaojun Zhang, Chang‐Shung Tung, Glenna Z. Sowa, Ma’mon M. Hatmal, Ian S. Haworth, Peter Zhifeng Qin	2012	46
11	Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors Vaccines ·Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin Naser Olaimat, Rohimah Mohamud, Mirna A. Fawaz, Elham Talib Kateeb, Omar K. Alkhairy, Reema Tayyem	2022	46
12	Conformational Variants of Duplex DNA Correlated with Cytosine-rich Chromosomal Fragile Sites Journal of Biological Chemistry ·Albert G. Tsai, Aaron E. Engelhart, Ma’mon M. Hatmal, Sabrina I. Houston, Nicholas V. Hud, Ian S. Haworth, Michael R. Lieber	2008	42
13	Exploring the influence of culture conditions on kefir's anticancer properties Journal of Dairy Science ·Ma’mon M. Hatmal, Abeer Nuirat, Malek A. Zihlif, Mutasem O. Taha	2018	41
14	Selection and targeting of EpCAM protein by ssDNA aptamer PLoS ONE ·Walhan Alshaer, Nidaa A. Ababneh, Ma’mon M. Hatmal, Heba Izmirli, Moujab Choukeife, Ala’a S. Shraim, Nour Sharar, Aya Abu-Shiekah	2017	39
15	Applications of Alginate-Based Nanomaterials in Enhancing the Therapeutic Effects of Bee Products Frontiers in Molecular Biosciences ·Mohammad A. I. Al-Hatamleh, Walhan Alshaer, Ma’mon M. Hatmal, Lidawani Lambuk, Naveed Ahmed, Mohd Zulkifli Mustafa, Siew Chun Low, Juhana Jaafar	2022	36
16	Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades Pharmaceutics ·Ihab Shawish, Assem Barakat, Ali K. Aldalbahi, Walhan Alshaer, Fadwa Daoud, Dana A. Alqudah, Mazhar Salim Al Zoubi, Ma’mon M. Hatmal	2022	32
17	Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin International Journal of Molecular Sciences ·Walhan Alshaer, Dana A. Alqudah, Suha Wehaibi, Duaa Azmi Abuarqoub, Malek A. Zihlif, Ma’mon M. Hatmal, Abdalla Awidi	2019	31
18	Common and Potential Emerging Foodborne Viruses: A Comprehensive Review Life ·Amin Naser Olaimat, Asma’ O. Taybeh, Anas A. Al‐Nabulsi, Murad Al‐Holy, Ma’mon M. Hatmal, Jihad A. M. Alzyoud, Iman Aolymat, Mahmoud H. Abughoush	2024	29
19	Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies Journal of Computer-Aided Molecular Design ·Ma’mon M. Hatmal, Shadi Jaber, Mutasem O. Taha	2016	29
20	1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP‑1 Differentiated Macrophages ACS Omega ·Ismail Sami Mahmoud, Ma’mon M. Hatmal, Duaa Azmi Abuarqoub, Ezaldeen Esawi, Hiba M. Zalloum, Suha Wehaibi, Hamdi Nouri Nsairat, Walhan Alshaer	2021	27

About Ma’mon M. Hatmal

Ma’mon M. Hatmal is a scholar working on Infectious Diseases, Computational Theory and Mathematics, Molecular Biology, Health and Biophysics, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Vaccine Coverage and Hesitancy (5 papers), Electron Spin Resonance Studies (4 papers), Lanthanide and Transition Metal Complexes (4 papers), Synthesis and biological activity (4 papers), COVID-19 epidemiological studies (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Infectious Diseases (328 citations), Biophysics (102 citations), Health (121 citations), Virology (64 citations) and Obstetrics and Gynecology (79 citations). Ma’mon M. Hatmal has collaborated with scholars based in Jordan, United States and Malaysia. Frequent co-authors include Walhan Alshaer, Mutasem O. Taha, Mohammad A. I. Al-Hatamleh, Rohimah Mohamud, Abdalla Awidi, Amin Naser Olaimat, Abdulfattah Al-Kadash, Alaa A. A. Aljabali, Lobna F. Gharaibeh and Hadil Zureigat. Their work appears in journals such as RSC Advances, Journal of Computer-Aided Molecular Design, Vaccines, European Journal of Pharmacology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ma’mon M. Hatmal

Impact in

Papers in i

In The Last Decade

Ma’mon M. Hatmal

Ma’mon M. Hatmal's Hit Papers

Peers

Countries citing papers authored by Ma’mon M. Hatmal

Fields of papers citing papers by Ma’mon M. Hatmal

All Works

About Ma’mon M. Hatmal

Explore authors with similar magnitude of impact

Papers in